Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 2:09 AM
Ignite Modification Date: 2025-12-26 @ 12:36 AM
NCT ID: NCT00401960
Description: None
Frequency Threshold: 0
Time Frame: 2 years; however, study terminated due to lack of eligible study participants
Study: NCT00401960
Study Brief: Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Adjunctive Daptomycin Group please see study description for study enrollment None None 5 5 0 5 View
Standard of Care Group as per study description None None 0 1 0 1 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
hemopericardium SYSTEMATIC_ASSESSMENT Cardiac disorders None View
death SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Cr elevation SYSTEMATIC_ASSESSMENT Renal and urinary disorders None View
death SYSTEMATIC_ASSESSMENT Infections and infestations None View
Other Events(If Any):